Elevated SUA reduces nitric oxide bioavailability via eNOS uncoupling, exacerbating hypertension,31,39 while simultaneously activating pro-inflammatory pathways (e.g., NLRP3/NF-κB) that weaken vascular integrity.34 The gene discussed is NLRP3; the disease is hypertensive disorder.